Cargando…
Neuroprotective Effects of Doxycycline in the R6/2 Mouse Model of Huntington’s Disease
Mechanisms of tissue damage in Huntington’s disease involve excitotoxicity, mitochondrial damage, and inflammation, including microglia activation. Immunomodulatory and anti-protein aggregation properties of tetracyclines were demonstrated in several disease models. In the present study, the neuropr...
Autores principales: | Paldino, Emanuela, Balducci, Claudia, La Vitola, Pietro, Artioli, Luisa, D’Angelo, Vincenza, Giampà, Carmela, Artuso, Vladimiro, Forloni, Gianluigi, Fusco, Francesca R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7118056/ https://www.ncbi.nlm.nih.gov/pubmed/31879858 http://dx.doi.org/10.1007/s12035-019-01847-8 |
Ejemplares similares
-
PARP-1 Inhibition Is Neuroprotective in the R6/2 Mouse Model of Huntington’s Disease
por: Cardinale, Antonella, et al.
Publicado: (2015) -
Selective Sparing of Striatal Interneurons after Poly (ADP-Ribose) Polymerase 1 Inhibition in the R6/2 Mouse Model of Huntington’s Disease
por: Paldino, Emanuela, et al.
Publicado: (2017) -
Modulation of Phospho-CREB by Systemically Administered Recombinant BDNF in the Hippocampus of the R6/2 Mouse Model of Huntington's Disease
por: Paldino, Emanuela, et al.
Publicado: (2019) -
Pyroptotic cell death in the R6/2 mouse model of Huntington’s disease: new insight on the inflammasome
por: Paldino, Emanuela, et al.
Publicado: (2020) -
Modulation of Inflammasome and Pyroptosis by Olaparib, a PARP-1 Inhibitor, in the R6/2 Mouse Model of Huntington’s Disease
por: Paldino, Emanuela, et al.
Publicado: (2020)